[4-[(E)-N-methoxy-C-methylcarbonimidoyl]-2-[(E)-prop-1-enyl]phenyl] acetate
C14H17NO3 — CID 142752164
Data last refreshed: (MolForge compound catalog, from PubChem)
About [4-[(E)-N-methoxy-C-methylcarbonimidoyl]-2-[(E)-prop-1-enyl]phenyl] acetate
[4-[(E)-N-methoxy-C-methylcarbonimidoyl]-2-[(E)-prop-1-enyl]phenyl] acetate (PubChem CID 142752164) has the molecular formula C14H17NO3 and a molecular weight of 247.29 g/mol. Its IUPAC name is [4-[(E)-N-methoxy-C-methylcarbonimidoyl]-2-[(E)-prop-1-enyl]phenyl] acetate.
Molecular Properties
| Compound Name | [4-[(E)-N-methoxy-C-methylcarbonimidoyl]-2-[(E)-prop-1-enyl]phenyl] acetate |
|---|---|
| PubChem CID | 142752164 |
| Molecular Formula | C14H17NO3 |
| Molecular Weight | 247.29 g/mol |
| Exact Mass | 247.12 |
| IUPAC Name | [4-[(E)-N-methoxy-C-methylcarbonimidoyl]-2-[(E)-prop-1-enyl]phenyl] acetate |
| SMILES | C/C=C/c1cc(/C(C)=N/OC)ccc1OC(C)=O |
| InChI | InChI=1S/C14H17NO3/c1-5-6-13-9-12(10(2)15-17-4)7-8-14(13)18-11(3)16/h5-9H,1-4H3/b6-5+,15-10+ |
| InChIKey | ATGBYYDGUVXYLD-YQTAKPNYSA-N |
| XLogP | 3.02 |
| TPSA | 47.89 Ų |
| H-Bond Donors | |
| H-Bond Acceptors | 4 |
| Rotatable Bonds | 4 |
| Heavy Atoms | 18 |
| Complexity | — |
Lipinski Rule of Five
Passes Rule of Five
| Rule | Value |
|---|---|
| MW ≤ 500 | 247.29 |
| LogP ≤ 5 | 3.02 |
| H-Bond Donors ≤ 5 | 0 |
| H-Bond Acceptors ≤ 10 | 4 |
Computed Properties (RDKit)
| Structural Alerts | {'alert_name': 'imine_1', 'substructure': 'N/A'}, {'alert_name': 'Oxygen-nitrogen_single_bond', 'substructure': 'N/A'}, {'alert_name': 'phenol_ester', 'substructure': 'N/A'} |
|---|
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 142752164 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.